UK TRADING UPDATE SUMMARY: Bluebird To Buy Southern Gold Venture Stake Read More
Syncona Investee Freeline Therapeutics Files For Possible US Listing Read More
Syncona's Investee Freeline Publishes Further Data For FLT180a Read More
Syncona Investee Freeline Raises USD120 Million And Mulls US Listing Read More
DIRECTOR DEALINGS: Syncona Non-Exec Reverberi Buys GBP50,000 In Shares Read More
Former Bayer Healthcare Chief Medical Officer Malik Joins Syncona Read More
Syncona Annual Assets Take Hit From Autolus Value But Likes Portfolio Read More
UK Earnings, Trading Statements Calendar - Next 7 Days Read More
Syncona Investee Achilles Therapeutics Starts Melanoma Therapy Trial Read More
Syncona Makes USD51 Million Investment Into SwanBio Therapeutics Read More
Syncona, Arix Note US FDA Acceptance Of Autolus Drug Application Read More
Syncona Expects Delays In Clinical Trials Due To Virus Disruption Read More
DIRECTOR DEALINGS SUMMARY: Plus500 Team Spend GBP14 Million On Shares Read More
DIRECTOR DEALINGS SUMMARY: IAG Chair And Director Spend EUR1.2 Million Read More
Syncona Investee Presents Positive Data For Fabry, Gaucher Studies Read More
Syncona Investee Freeline Reports Positive Data From FLT180a Trial Read More
Syncona Net Assets Rise Slightly In "Productive" Third Quarter Read More
Syncona, Arix Note New Data From Autolus Trial Of AUTO3 Cell Therapy Read More
Syncona, Arix Note Pricing Of Public Offering By Autolus Therapeutics Read More
Syncona Commits USD80 Million Investment Into Freeline Therapeutics Read More
